Publishing research using ab39162? Please let us know so that we can cite the reference in this datasheet.
ab39162 has been referenced in 5 publications.
- Bolino A et al. Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination. EMBO Mol Med 8:1438-1454 (2016). PubMed: 27799291
- Fleck D et al. Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling. J Neurosci 33:7856-69 (2013). PubMed: 23637177
- Rothhaar TL et al. Plasmalogens Inhibit APP Processing by Directly Affecting ?-Secretase Activity in Alzheimer's Disease. ScientificWorldJournal 2012:141240 (2012). WB ; Human . PubMed: 22547976
- Marballi K et al. Differential neuregulin 1 cleavage in the prefrontal cortex and hippocampus in schizophrenia and bipolar disorder: preliminary findings. PLoS One 7:e36431 (2012). WB ; Human . PubMed: 22590542
- Grimm MO et al. Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. J Biol Chem 286:14028-39 (2011). Human . PubMed: 21324907
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"